APA (7th ed.) Citation

Keystone, E., Burmester, G. R., Fume, R., Loveless, J. E., Emery, P., Kremer, J., . . . Jost, F. (2008). Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy. Arthritis & Rheumatism, 58(6), 785. https://doi.org/10.1002/art.23715

Chicago Style (17th ed.) Citation

Keystone, E., et al. "Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy." Arthritis & Rheumatism 58, no. 6 (2008): 785. https://doi.org/10.1002/art.23715.

MLA (9th ed.) Citation

Keystone, E., et al. "Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy." Arthritis & Rheumatism, vol. 58, no. 6, 2008, p. 785, https://doi.org/10.1002/art.23715.